These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Biochemical research in schizophrenia. Boulton AA Nature; 1971 May; 231(5297):22-8. PubMed ID: 4930468 [No Abstract] [Full Text] [Related]
6. The "pink spot" and schizophrenia. Boulton AA; Felton CA Nature; 1966 Sep; 211(5056):1404-5. PubMed ID: 5969835 [No Abstract] [Full Text] [Related]
7. A biochemical and perceptual measure related to length of hospitalization. Kelm H; Hall RW; Hoffer A Dis Nerv Syst; 1968 Dec; 29(12):844-5. PubMed ID: 5717300 [No Abstract] [Full Text] [Related]
8. Identity of the "pink spot". Bell CE; Somerville AR Nature; 1966 Sep; 211(5056):1405-6. PubMed ID: 5969836 [No Abstract] [Full Text] [Related]
11. [Current status of studies on dimethoxyphenylethylamine in schizophrenia]. Friedhoff AJ Vestn Akad Med Nauk SSSR; 1969; 24(4):37-41. PubMed ID: 5346213 [No Abstract] [Full Text] [Related]
12. The possible significance of cerebral dopamine for neurology and psychiatry. van Praag HM Psychiatr Neurol Neurochir; 1967; 70(5):361-79. PubMed ID: 4862827 [No Abstract] [Full Text] [Related]
13. Aspects of tyrosine metabolism in schizophrenia. Williams CH Psychol Med; 1971 Aug; 1(4):286-91. PubMed ID: 5149869 [No Abstract] [Full Text] [Related]
14. [Contibution to the significance of 3,4-dimethoxyphenylethylamine in schizophrenias]. Hanzlícek L Cesk Psychiatr; 1967 Oct; 63(5):293-6. PubMed ID: 6065348 [No Abstract] [Full Text] [Related]
15. A new concept and further support for the importance and occurrence of 3,4-dimethoxyphenylethylamine (DMPEA) in urine of schizophrenic patients. Kalbhen DA; Braun G Pharmacology; 1973; 9(1):52-6. PubMed ID: 4708978 [No Abstract] [Full Text] [Related]
16. [Excretion of 3,4-dimethoxyphenylethylamine. Central and peripheral synthesis]. Dávila R; Zumárraga M; Zamalloa MI; Friedhoff AJ Arch Neurobiol (Madr); 1984; 47(1):19-28. PubMed ID: 6721632 [No Abstract] [Full Text] [Related]
17. Schizophrenia and pink spot. Stam FC; Heslinga FJ; van Tilburg W Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242 [No Abstract] [Full Text] [Related]
18. 3,4-dimethoxyphenethylamine (DMPEA) and schizophrenia. Narasimhachari N Biol Psychiatry; 1979 Feb; 14(1):215-9. PubMed ID: 420902 [No Abstract] [Full Text] [Related]
19. Investigations on urinary excretion of 3,4 dimethoxyphenylethylamine (the pink spot), the Mauve factor and aromatic compounds in patients with schizophrenia. Rao BS; Narayanan HS; Reddy GN Indian J Med Res; 1971 Mar; 59(3):455-60. PubMed ID: 5090025 [No Abstract] [Full Text] [Related]
20. Pink spot in the urine and C.S.F. of schizophrenics. Sharma S; Sinari VP Dis Nerv Syst; 1971 Dec; 32(12):831-4. PubMed ID: 5139206 [No Abstract] [Full Text] [Related] [Next] [New Search]